Integrant Awarded Nasdaq Ticker "INGT" Ahead of Highly Anticipated IPO
Affected assets and topics
Why it matters
FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.
Expected market reaction
Evidence trail
Evidence
Source
Yahoo Finance
Claim
Integrant Awarded Nasdaq Ticker "INGT" Ahead of Highly Anticipated IPO
Affected assets
NASDAQ
AI inference
Neutral · 94%
Generated
2026-04-16 06:30
AI provenance
Technical identifiers
- Provider tag
- huggingface-ProsusAI/finbert
- Model id
- prosusai/finbert
- Analysis version
- huggingface-ProsusAI/finbert
- Article id
- 71742
- Timeframe
- 6h
Prediction lifecycle
-
FinBERT NASDAQ Neutral 94%Generated 6h Verified
Scored correct
Logged at publication, scored automatically once the window closes — never edited.
Actual outcome
Asset
NASDAQ
Reference price
24102.70000000
Price at evaluation
24016.02000000
Change
-0.3596%
Result
Scored correct
Original source
SYDNEY, April 16, 2026--Integrant (INGT) awarded Nasdaq ticker ahead IPO, advancing AI-driven regenerative medicine and orthopaedic therapies from Sydney Australia.
Read the full article on Yahoo Finance
Original article published by Yahoo Finance on April 16, 2026. Analysis and insights provided by AnalystMarkets AI.
This model on similar stories
FinBERT · 89.9% correct across 446 scored calls on indices See the full record